Phosphatidylinositol (PI) is a component of membrane phospholipids functioning both as a signaling molecule and as a compartment-specific localization signal in form of polyphosphoinositides. Arachidonic acid (AA) is the predominant fatty acid in the sn-2 position of PI in mammals. LysoPI acyltransferase (LPIAT) is thought to catalyze formation of AA-containing PI; however, the gene that encodes this enzyme has not yet been identified. In this study, we established a screening system to identify genes required for utilization of exogenous polyunsaturated fatty acids in C. elegans, in which eicosapentaenoic acid (EPA) instead of AA is dominant in PI. We found that a previously uncharacterized gene, which we named
mboa-7, is required for incorporation of PUFAs into PI. Incorporation of exogenous EPA into PI of the living worms and the in vitro incorporation of EPA into lysoPI by the microsomal fraction were greatly reduced in
mboa-7 mutants while the incorporation of EPA into other phospholipids was unaffected in both systems. siRNA of human
mboa-7 homologue (MBOAT7) in HeLa cells also reduced AA incorporation into PI at cellular level and in vitro. Furthermore, the membrane fractions of transgenic worms expressing recombinant MBOA-7 and MBOAT7 exhibited remarkably increased LPIAT activity but not other lysophospholipid acyltransferase activity. Finally,
mboa-7 mutants had greatly reduced EPA content in PI but not in other phospholipids. These data demonstrated for the first time that C. elegans
mboa-7 and its mammalian homologue MBOAT7 are LPIAT functioning as a determinant of PI molecular species.In this meeting, we will present our recent data on both
mboa-7 knockout worms and knockout mice.